Fiorenzuola d'Arda, Italy

Maria Bergamaschi

This inventor holds 1 USPTO granted patent. Top assignee: Farmitalia Carlo Erba. Active years: 1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Bergamaschi. Retrieved from https://idiyas.com/inventor/maria-bergamaschi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Bergamaschi: Innovator in Pharmaceutical Chemistry

Introduction

Maria Bergamaschi is a notable inventor based in Fiorenzuola d'Arda, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development of new compounds.

Latest Patents

Maria holds a patent for her work on 3-(1-Imidazolyl)-derivatives of 2,3-dihydro-4H-1-benzopyran. This patent includes compounds such as 3-(1-imidazolyl)-2,3-dihydro-4H-1-benzopyran-4-one. The patent also discloses methods for synthesizing these compounds and pharmaceutical compositions that incorporate them. These compounds have potential applications in inhibiting blood platelet aggregation, increasing total serum HDL cholesterol, and reducing total serum cholesterol or serum triglycerides.

Career Highlights

Maria is currently employed at Farmitalia Carlo Erba, where she continues to advance her research in pharmaceutical innovations. Her work has been instrumental in developing new therapeutic strategies that can improve health outcomes.

Collaborations

Maria collaborates with esteemed colleagues such as Paolo Cozzi and Nicola Mongelli, contributing to a dynamic research environment that fosters innovation.

Conclusion

Maria Bergamaschi exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patent and ongoing research are paving the way for new treatments and advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…